Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00479
|
|||||
Drug Name |
Dilazep
|
|||||
Synonyms |
3-{4-[3-(3,4,5-trimethoxybenzoyloxy)propyl]-1,4-diazepan-1-yl}propyl 3,4,5-trimethoxybenzoate; AS 05; Benzoic acid, 3,4,5-trimethoxy-, (tetrahydro-1H-1,4-diazepine-1,4(5H)-diyl)di-3,1-propanediyl ester; CHEMBL126075; DSSTox_CID_25425; DSSTox_GSID_45425; DSSTox_RID_80871; Dilazep (INN); Dilazep [INN]; Dilazepam; Dilazepam [INN-Spanish]; Dilazepum; Dilazepum [INN-Latin]; F8KLC2BD5Z; NCGC00016747-03; Tetrahydro-1H-1,4-diazepine-1,4(5H)-dipropanol 3,4,5-trimethoxybenzoate (diester); UNII-F8KLC2BD5Z
|
|||||
Drug Type |
Small molecular drug
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C31H44N2O10
|
|||||
Canonical SMILES |
COC1=CC(=CC(=C1OC)OC)C(=O)OCCCN2CCCN(CC2)CCCOC(=O)C3=CC(=C(C(=C3)OC)OC)OC
|
|||||
InChI |
InChI=1S/C31H44N2O10/c1-36-24-18-22(19-25(37-2)28(24)40-5)30(34)42-16-8-12-32-10-7-11-33(15-14-32)13-9-17-43-31(35)23-20-26(38-3)29(41-6)27(21-23)39-4/h18-21H,7-17H2,1-6H3
|
|||||
InChIKey |
QVZCXCJXTMIDME-UHFFFAOYSA-N
|
|||||
Pharmaceutical Properties | Molecular Weight | 604.7 | Topological Polar Surface Area | 115 | ||
Heavy Atom Count | 43 | Rotatable Bond Count | 18 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 12 | |||
XLogP |
4.1
|
|||||
PubChem CID | ||||||
PubChem SID |
103358664
, 103827128
, 103928959
, 104171321
, 104302450
, 109716887
, 109716888
, 11112657
, 11113524
, 11466264
, 11467384
, 11485968
, 117582298
, 124882501
, 124882502
, 124882503
, 125082093
, 129083017
, 134223538
, 134999161
, 137241854
, 142472737
, 144204139
, 14813845
, 162092496
, 170465831
, 176484247
, 178101428
, 179150376
, 184547168
, 198939262
, 221672745
, 26751736
, 29222219
, 47515482
, 48110615
, 48185145
, 48185146
, 48259422
, 49698400
, 49888469
, 5021257
, 50575210
, 57321593
, 7979090
, 8151954
, 85085490
, 85788400
, 92309007
, 96024540
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.